New Zealand vs Nigeria: Access to anti-retroviral drugs, male
New Zealand
85.0%
in 2024
Nigeria
84.0%
in 2024
New Zealand rank
34th
Nigeria rank
36th
Access to anti-retroviral drugs, male over time
- New Zealand
- Nigeria
How they compare
New Zealand currently reports 85.0% against 84.0% in Nigeria, a difference of 1.0%.
Across all 25 years both countries report, New Zealand has been ahead every year.
New Zealand ranks 34th and Nigeria ranks 36th of 141 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.9% | 5.3% | 36.6% | New Zealand |
| 2010s | 63.7% | 29.6% | 34.1% | New Zealand |
| 2020s | 80.0% | 68.0% | 12.0% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, New Zealand or Nigeria?
- New Zealand, at 85.0% against 84.0% in Nigeria as of 2024.
- What is the difference in access to anti-retroviral drugs, male between New Zealand and Nigeria?
- 1.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Nigeria?
- 25 years are reported by both, from 2000 to 2024.
- How do New Zealand and Nigeria rank globally for access to anti-retroviral drugs, male?
- New Zealand ranks 34th and Nigeria ranks 36th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.